References
- 1. Cooper DS, Doherty GM, Haugen BR, et al. (2009). Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19:1167–1214.
- 2. Pacini F, Schlumberger M, Dralle H, et al. (2006). European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol, 154:787–803.
- 3. Feldt-Rasmussen U, Profilis C, Colinet E, et al. (1996). Human thyroglobulin reference material (CRM 457). 1st part: assessment of homogeneity, stability and immunoreactivity. Annales de Biologie Clinique Paris, 54:337–342.
- 4. Stanojevic M, Savin S, Cvejic D, et al. (2009). Correlation of thyroglobulin concentrations measured by radioimmunoassay and immunometric assay and the influence of thyroglobulin antibody. J Immunoassay Immunochem, 30:197-207.
- 5. Stanojevic M, Savin S, Cvejic D, et al. (2009). Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients. J Clin Lab Anal, 23:341-346.
- 6. Görges R, Maniecki M, Jentzen W, et al. (2005). Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol,153:49-55.
- 7. Spencer CA, LoPresti JS. (2008). Technology insight: Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Endocrinol Metab,4:223-233.
- 8. Spencer CA, Bergoglio LM, Kazarosyan M, et al. (2005). Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab, 90:5566-5575.
- 9. Cheng X, Yu S, Jin C, Han S, et al. (2017). Comparison of three different assays for measuring thyroglobulin and thyroglobulin antibodies in patients with chronic lymphocytic thyroiditis. Clinical Biochemistry, 50(18):1183-1187.
- 10. Giovanella L, Clark P, Chiovato L, et al. (2014). Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper. Eur J Endocrinol, 171:R33–R46
- 11. Netzel BC, Grebe SKG, Carranza Leon BG, et al. (2015). Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes. The Journal of Clinical Endocrinology and Metabolism, 100(8):E1074-E1083. doi:10.1210/jc.2015-1967.
- 12. Schlumberger M, Hitzel A, Toubert ME, et al. (2007). Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab, 92:2487–2495.
- 13. Okosieme OE, Evans C, Moss L, et al. (2005). Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery. Clin Chem, 51(4):729-734.
- 14. Estienne B, McIntosh RS, Ruf J, et al. (1998). Comparative mapping of cloned human and murine antithyroglobulin antibodies: recognition of human antibodies of an immunodominant region. Thyroid, 8: 643–648.
- 15. Lee JI, Kim JY, Choi JY, et al. (2010). Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457) Head Neck, 32:1161–1166.
- 16. Spencer C, Fatemi S. (2013). Thyroglobulin antibody (TgAb) methods -Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer. Best Pract Res Clin Endocrinol Metab, 27:701–712.
- 17. Mazzaferri EL, Robbins RJ, Spencer CA, et al. (2003). A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab, 88(4):1433-1441.
- 18. Vrndic O, Savin S, Mijatovic Lj, et al. (2011). Concentration of Thyroglobulin and Thyroglobulin-Specific Autoantibodies in Patients With Differentiated Thyroid Cancer After Treatment With Radioactive Iodine 131, Lab Medicine, 42(1):27–31
- 19. Cho YY, Chun S, Lee S-Y, et al. (2016). Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer. Ann Lab Med, 36(5):413-419. doi:10.3343/alm.2016.36.5.413.
- 20. Spencer C, LoPresti J, Fatemi S. (2014). How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies. Curr Opin Endocrinol Diabetes Obes,21(5):394-404. doi: 10.1097/MED.0000000000000092.